{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T12:41:05Z","timestamp":1769517665992,"version":"3.49.0"},"reference-count":32,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":623,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharmacology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1002\/jcph.230","type":"journal-article","created":{"date-parts":[[2013,11,11]],"date-time":"2013-11-11T12:20:40Z","timestamp":1384172440000},"page":"215-224","source":"Crossref","is-referenced-by-count":19,"title":["CYP3A5*3 and bilirubin predict midazolam population pharmacokinetics in Asian cancer patients"],"prefix":"10.1002","volume":"54","author":[{"given":"Kok-Yong","family":"Seng","sequence":"first","affiliation":[{"name":"Yong Loo Lin School of Medicine; National University of Singapore; Singapore Singapore"},{"name":"Defence Medical & Environmental Research Institute; DSO National Laboratories; Singapore Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim-Hor","family":"Hee","sequence":"additional","affiliation":[{"name":"Yong Loo Lin School of Medicine; National University of Singapore; Singapore Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaik Hong","family":"Soon","sequence":"additional","affiliation":[{"name":"Yong Loo Lin School of Medicine; National University of Singapore; Singapore Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nur Sabrina","family":"Sapari","sequence":"additional","affiliation":[{"name":"Cancer Science Institute of Singapore; National University of Singapore; Singapore Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richie","family":"Soong","sequence":"additional","affiliation":[{"name":"Cancer Science Institute of Singapore; National University of Singapore; Singapore Singapore"},{"name":"Department of Pathology; National University Health System; Singapore Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boon-Cher","family":"Goh","sequence":"additional","affiliation":[{"name":"Cancer Science Institute of Singapore; National University of Singapore; Singapore Singapore"},{"name":"National University Health System; Singapore Singapore"},{"name":"Haematology Oncology Research Group; National University Cancer Institute of Singapore, National University Health System; Singapore Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence Soon-U","family":"Lee","sequence":"additional","affiliation":[{"name":"Yong Loo Lin School of Medicine; National University of Singapore; Singapore Singapore"},{"name":"National University Health System; Singapore Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,12,17]]},"reference":[{"issue":"2","key":"10.1002\/jcph.230-BIB0001|jcph230-cit-0001","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/01.ftd.0000194497.55269.d9","article-title":"Ketoconazole renders poor CYP3A phenotype status with midazolam as probe drug","volume":"28","author":"Tham","year":"2006","journal-title":"Ther Drug Monit."},{"issue":"12","key":"10.1002\/jcph.230-BIB0002|jcph230-cit-0002","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1158\/1078-0432.CCR-07-0088","article-title":"Differential metabolism of gefitinib and erlotinib by human cytochrome P450 enzymes","volume":"13","author":"Li","year":"2007","journal-title":"Clin Cancer Res."},{"issue":"3","key":"10.1002\/jcph.230-BIB0003|jcph230-cit-0003","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00008571-200004000-00001","article-title":"Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes","volume":"10","author":"Streetman","year":"2000","journal-title":"Pharmacogenetics."},{"issue":"5","key":"10.1002\/jcph.230-BIB0004|jcph230-cit-0004","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/0091270003252519","article-title":"The conduct of in vitro and in vivo drug-drug interaction studies: a PhRMA perspective","volume":"43","author":"Bjornsson","year":"2003","journal-title":"J Clin Pharmacol."},{"issue":"9","key":"10.1002\/jcph.230-BIB0005|jcph230-cit-0005","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/0006-2952(94)90543-6","article-title":"Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily","volume":"47","author":"Gorski","year":"1994","journal-title":"Biochem Pharmacol."},{"issue":"12a","key":"10.1002\/jcph.230-BIB0006|jcph230-cit-0006","first-page":"2220","article-title":"Excretion and metabolism of 14C-midazolam in humans following oral dosing","volume":"31","author":"Heizmann","year":"1981","journal-title":"Arzneimittel-Forschung."},{"issue":"2","key":"10.1002\/jcph.230-BIB0007|jcph230-cit-0007","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/dmd.107.017962","article-title":"Characterization of 1'-hydroxymidazolam glucuronidation in human liver microsomes","volume":"36","author":"Zhu","year":"2008","journal-title":"Drug Metab Dispos."},{"issue":"11","key":"10.1002\/jcph.230-BIB0008|jcph230-cit-0008","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1124\/dmd.110.035295","article-title":"Metabolism of 1'- and 4-hydroxymidazolam by glucuronide conjugation is largely mediated by UDP-glucuronosyltransferases 1A4, 2B4, and 2B7","volume":"38","author":"Seo","year":"2010","journal-title":"Drug Metab Dispos."},{"issue":"5","key":"10.1002\/jcph.230-BIB0009|jcph230-cit-0009","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.clpt.2004.11.112","article-title":"Genotype-phenotype associations of cytochrome P450 3A4 and 3A5 polymorphism with midazolam clearance in vivo","volume":"77","author":"He","year":"2005","journal-title":"Clin Pharmacol Ther."},{"issue":"3","key":"10.1002\/jcph.230-BIB0010|jcph230-cit-0010","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1046\/j.1365-2125.2003.01767.x","article-title":"Phenotyping CYP3A using midazolam in cancer and noncancer Asian patients","volume":"55","author":"Lee","year":"2003","journal-title":"Br J Clin Pharmacol."},{"issue":"4","key":"10.1002\/jcph.230-BIB0011|jcph230-cit-0011","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00228-004-0767-7","article-title":"Pharmacokinetics of midazolam in CYP3A4- and CYP3A5-genotyped subjects","volume":"60","author":"Eap","year":"2004","journal-title":"Eur J Clin Pharmacol."},{"issue":"6","key":"10.1002\/jcph.230-BIB0012|jcph230-cit-0012","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2044.1987.tb03086.x","article-title":"Failure of critically ill patients to metabolise midazolam","volume":"42","author":"Shelly","year":"1987","journal-title":"Anaesthesia."},{"issue":"3","key":"10.1002\/jcph.230-BIB0013|jcph230-cit-0013","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/clpt.1988.31","article-title":"Clinical pharmacokinetics of midazolam in intensive care patients, a wide interpatient variability","volume":"43","author":"Oldenhof","year":"1988","journal-title":"Clin Pharmacol Ther."},{"issue":"2","key":"10.1002\/jcph.230-BIB0014|jcph230-cit-0014","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00000542-200108000-00007","article-title":"A double-blind, randomized comparison of i.v. lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model","volume":"95","author":"Barr","year":"2001","journal-title":"Anesthesiology."},{"issue":"2","key":"10.1002\/jcph.230-BIB0015|jcph230-cit-0015","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-2125.2003.01957.x","article-title":"Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients","volume":"57","author":"Swart","year":"2004","journal-title":"Br J Clin Pharmacol."},{"issue":"8968","key":"10.1002\/jcph.230-BIB0016|jcph230-cit-0016","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(95)91209-6","article-title":"Prolonged sedation due to accumulation of conjugated metabolites of midazolam","volume":"346","author":"Bauer","year":"1995","journal-title":"Lancet."},{"issue":"4","key":"10.1002\/jcph.230-BIB0017|jcph230-cit-0017","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF00562804","article-title":"The pharmacokinetics of midazolam in man","volume":"19","author":"Smith","year":"1981","journal-title":"Eur J Clin Pharmacol."},{"issue":"8","key":"10.1002\/jcph.230-BIB0018|jcph230-cit-0018","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/00003246-199208000-00010","article-title":"Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patients","volume":"20","author":"Malacrida","year":"1992","journal-title":"Crit Care Med."},{"key":"10.1002\/jcph.230-BIB0019|jcph230-cit-0019","first-page":"584","article-title":"Simultaneous determination of probe drugs, metabolites, inhibitors and inducer in human plasma by liquid chromatography\/tandem mass spectrometry and its application to pharmacokinetic study","volume":"88C","author":"Hee","year":"2013","journal-title":"J Pharm Biomed Anal."},{"issue":"2","key":"10.1002\/jcph.230-BIB0020|jcph230-cit-0020","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/jms.1874","article-title":"Simultaneous determination of raltegravir and raltegravir glucuronide in human plasma by liquid chromatography-tandem mass spectrometric method","volume":"46","author":"Wang","year":"2010","journal-title":"J Mass Spectrom."},{"key":"10.1002\/jcph.230-BIB0021|jcph230-cit-0021","unstructured":"Beal S Sheiner LB Boekmann A Bauer RJ. 2009"},{"issue":"3","key":"10.1002\/jcph.230-BIB0022|jcph230-cit-0022","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cmpb.2005.04.005","article-title":"PsN-Toolkit-a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM","volume":"79","author":"Lindbom","year":"2005","journal-title":"Comput Methods Programs Biomed."},{"issue":"3","key":"10.1002\/jcph.230-BIB0023|jcph230-cit-0023","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1208\/s12248-009-9133-0","article-title":"Importance of shrinkage in empirical bayes estimates for diagnostics: problems and solutions","volume":"11","author":"Savic","year":"2009","journal-title":"AAPS J."},{"issue":"1","key":"10.1002\/jcph.230-BIB0024|jcph230-cit-0024","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0169-2607(98)00067-4","article-title":"Xpose-an S-PLUS based population pharmacokinetic\/pharmacodynamic model building aid for NONMEM","volume":"58","author":"Jonsson","year":"1999","journal-title":"Comput Methods Programs Biomed."},{"issue":"1","key":"10.1002\/jcph.230-BIB0025|jcph230-cit-0025","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.0006-341X.2001.00120.x","article-title":"Akaike's information criterion in generalized estimating equations","volume":"57","author":"Pan","year":"2001","journal-title":"Biometrics."},{"issue":"2","key":"10.1002\/jcph.230-BIB0026|jcph230-cit-0026","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1053\/j.ajkd.2004.09.004","article-title":"Population pharmacokinetics of lorazepam and midazolam and their metabolites in intensive care patients on continuous venovenous hemofiltration","volume":"45","author":"Swart","year":"2005","journal-title":"Am J Kidney Dis."},{"issue":"5","key":"10.1002\/jcph.230-BIB0027|jcph230-cit-0027","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2165\/00003088-199630050-00001","article-title":"A size standard for pharmacokinetics","volume":"30","author":"Holford","year":"1996","journal-title":"Clin Pharmacokinet."},{"issue":"24","key":"10.1002\/jcph.230-BIB0028|jcph230-cit-0028","doi-asserted-by":"crossref","first-page":"8341","DOI":"10.1158\/1078-0432.CCR-04-1371","article-title":"Factors affecting cytochrome P-450 3A activity in cancer patients","volume":"10","author":"Baker","year":"2004","journal-title":"Clin Cancer Res."},{"issue":"4","key":"10.1002\/jcph.230-BIB0029|jcph230-cit-0029","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/sj.clpt.6100237","article-title":"Influence of CYP3A5 genotype on the pharmacokinetics and pharmacodynamics of the cytochrome P4503A probes alfentanil and midazolam","volume":"82","author":"Kharasch","year":"2007","journal-title":"Clin Pharmacol Ther."},{"issue":"12","key":"10.1002\/jcph.230-BIB0030|jcph230-cit-0030","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00228-007-0365-6","article-title":"Impact of the CYP3A5 genotype on midazolam pharmacokinetics and pharmacodynamics during intensive care sedation","volume":"63","author":"Fromm","year":"2007","journal-title":"Eur J Clin Pharmacol."},{"issue":"10","key":"10.1002\/jcph.230-BIB0031|jcph230-cit-0031","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0169-409X(02)00066-2","article-title":"Genetic contribution to variable human CYP3A-mediated metabolism","volume":"54","author":"Lamba","year":"2002","journal-title":"Adv Drug Deliv Rev."},{"issue":"6","key":"10.1002\/jcph.230-BIB0032|jcph230-cit-0032","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.clpt.2004.02.005","article-title":"CYP3A5 genotype and midazolam clearance in Australian patients receiving chemotherapy","volume":"75","author":"Wong","year":"2004","journal-title":"Clin Pharmacol Ther."}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcph.230","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/jcph.230\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T13:02:57Z","timestamp":1657803777000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcph.230"}},"subtitle":["The Journal of Clinical Pharmacology"],"short-title":[],"issued":{"date-parts":[[2013,12,17]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"URL":"https:\/\/doi.org\/10.1002\/jcph.230","relation":{},"ISSN":["0091-2700"],"issn-type":[{"value":"0091-2700","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12,17]]}}}